Astrazeneca Pharma India Limited

Pharmaceutical company manufacturing and distributing products for various therapeutic areas.

1979 | Bangaluru, Karnataka (India) | Active
Last Updated:

Astrazeneca Pharma India Profile

Key Indicators

  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 5.00 Cr
  • Company Age 45 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 62.50 Cr
  • Revenue Growth 25.44%
  • Profit Growth 61.19%
  • Ebitda 91.60%
  • Net Worth 15.12%
  • Total Assets 14.98%

About Astrazeneca Pharma India

Astrazeneca Pharma India Limited (APIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 11 July 1979 and has a history of 45 years and ten months. Its registered office is in Bangaluru, Karnataka, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 506820 and on the National Stock Exchange(NSE) under ASTRAZEN.

The Corporate was formerly known as Astra Idl Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.

The company has closed loans amounting to ₹62.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Astrazeneca Pharma India Limited India are Bhavana Agrawal as CFO and Manasa Rama as Company Secretary. Revathy Ashok, Shilpa Divekar, Monica Widhani, and Five other members serve as directors at the Company.

Company Details

  • Location

    Bangaluru, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24231KA1979PLC003563

  • Company No.

    003563

  • Stock Symbol

    BSE : 506820 NSE : ASTRAZEN

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    11 Jul 1979

  • Date of AGM

    08 Aug 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Bangalore

Industry

Pharma
Company report

Astrazeneca Pharma India Limited

Explore comprehensive data for Astrazeneca Pharma India Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Astrazeneca Pharma India?

Executive Team (3)

NameDesignationAppointment DateStatus
Sanjeev Panchal Country flag representing In Managing Director01-Jan-2023Current
Bhavana Agrawal Country flag representing In CFO15-Mar-2024Current
Manasa Rama Company Secretary11-Aug-2022Current

Board Members (7)

NameDesignationAppointment DateStatus
Shilpa Divekar Country flag representing In Director 29-Dec-2021Current
Revathy Ashok Country flag representing In Director 02-Dec-2016Current
Monica Widhani Country flag representing In Additional Director 25-Sep-2024Current
Hooi Chuah Country flag representing My Director 09-Nov-2023Current
Sylvia Ramon Director 21-Dec-2023Current
Bhavana Agrawal Country flag representing In Whole-Time Director and Cfo 08-Feb-2024Current

Financial Performance of Astrazeneca Pharma India.

Astrazeneca Pharma India Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.44% increase. The company also saw a substantial improvement in profitability, with a 61.19% increase in profit. The company's net worth Soared by an impressive increase of 15.12%.

Astrazeneca Pharma India revenue growth over time
Astrazeneca Pharma India profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
25.44%
Revenue from Operations
24.50%
Total Assets
14.98%
Profit or Loss
61.19%
Net Worth
15.12%
EBITDA
91.60%

What is the Ownership and Shareholding Structure of Astrazeneca Pharma India?

In 2023, Astrazeneca Pharma India had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹62.50 Cr

Charges Breakdown by Lending Institutions

  • Il & Fs Trust Company Limited : 62.50 Cr

Latest Charge Details

DateLenderAmountStatus
16 Jan 2008Il & Fs Trust Company Limited₹62.50 CrSatisfied

How Many Employees Work at Astrazeneca Pharma India?

Astrazeneca Pharma India has a workforce of 935 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Astrazeneca Pharma India Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Astrazeneca Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astrazeneca Pharma India's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Astrazeneca Pharma India

Recent activity within the organization

  • Director Appointment

    Jesus Javier Diaz Ropero Esteso was appointed as a Additional Director was appointed as a Additional Director on 13 Nov 2024 & has been associated with this company since 6 months 1 day .

  • Director Appointment

    Monica Widhani was appointed as a Additional Director was appointed as a Additional Director on 25 Sep 2024 & has been associated with this company since 7 months 19 days .

  • Annual General Meeting

    Astrazeneca Pharma India Limited last Annual general meeting of members was held on 08 Aug 2024 as per latest MCA records.

  • Balance Sheet

    Astrazeneca Pharma India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

  • Director Appointment

    Bhavana Agrawal was appointed as a Cfo was appointed as a Cfo on 15 Mar 2024 & has been associated with this company since 1 year 2 months .

  • Director Appointment

    Bhavana Agrawal was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 08 Feb 2024 & has been associated with this company since 1 year 3 months .

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Astrazeneca Pharma India Limited?

    Astrazeneca Pharma India Limited was incorporated on 11 Jul 1979.

  • What is authorized share capital and paid-up capital of Astrazeneca Pharma India Limited?

    The authorized share capital of Astrazeneca Pharma India Limited is ₹ 5.00 Cr and paid-up capital is ₹ 5.00 Cr.

  • Who are the current board members & directors of Astrazeneca Pharma India Limited?

    Currently 10 directors are associated with Astrazeneca Pharma India Limited.

    • Revathy Ashok
    • Shilpa Shridhar Divekar
    • Monica Widhani
    • Sanjeev Kumar Panchal
    • Hooi Bien Chuah
    • Sylvia Lorena Varela Ramon
    • Bhavana Agrawal
    • Jesus Javier Diaz Ropero Esteso
    • Bhavana Agrawal
    • Manasa Rama

  • What is the registered address of Astrazeneca Pharma India Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Astrazeneca Pharma India Limited is Block N1 12Th Floor Manyata Embassy Business Park Rachenahalli, Outer Ring Road India, Bangalore, Karnataka, 560045.

  • What is the corporate identification number (CIN) and company number of Astrazeneca Pharma India Limited?

    The corporate identification number (CIN) of Astrazeneca Pharma India Limited is L24231KA1979PLC003563 and the company number is 003563 as per Ministry of Corporate Affairs (MCA).

  • Is Astrazeneca Pharma India Limited registered with any stock exchange in India?

    Yes, Astrazeneca Pharma India Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): ASTRAZEN.

  • What is the official website of Astrazeneca Pharma India Limited?

    The Official website of Astrazeneca Pharma India Limited is https://www.astrazeneca.in

  • What has been the recent revenue trend for Astrazeneca Pharma India Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Astrazeneca Pharma India Limited has risen by 25.44%.

  • How many employees does Astrazeneca Pharma India Limited currently have?

    As Per 2023 financial reports, 935 employees are currently employed by Astrazeneca Pharma India Limited.

  • What change has been observed in the net worth of Astrazeneca Pharma India Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Astrazeneca Pharma India Limited has experienced an upsurge of 15.12%.

  • When was the last Balance Sheet of Astrazeneca Pharma India Limited filed with the ROC?

    The most recent Balance Sheet for Astrazeneca Pharma India Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development